Financials

  • Market Capitalization 10.64 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
46.63
ratio cours/chiffre d'affaires
25.53

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
850
TECH
Bio-Techne Corp - Common Stock
72.31 USD-0.06%-0.07%+0.24%+33.49%11.34 B USD
869
SMMT
Summit Therapeutics Inc. - Common Stock
13.62 USD-0.80%+2.64%+5.17%-31.42%10.87 B USD
892
AXSM
Axsome Therapeutics, Inc. - Common Stock
198.52 USD-0.25%-4.36%-7.88%+52.47%10.40 B USD
917
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
60.36 USD-1.13%-2.94%+14.62%-16.31%10.03 B USD

Nouvelles